{"pmid":32281766,"title":"Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?","text":["Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?","J Trauma Acute Care Surg","Moore, Hunter B","Barrett, Christopher D","Moore, Ernest E","McIntyre, Robert C","Moore, Peter K","Talmor, Daniel S","Moore, Frederick A","Yaffe, Michael B","32281766"],"journal":"J Trauma Acute Care Surg","authors":["Moore, Hunter B","Barrett, Christopher D","Moore, Ernest E","McIntyre, Robert C","Moore, Peter K","Talmor, Daniel S","Moore, Frederick A","Yaffe, Michael B"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281766","week":"202016|Apr 13 - Apr 19","doi":"10.1097/TA.0000000000002694","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663989232713072640,"score":7.979339,"similar":[{"pmid":32267998,"title":"Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series.","text":["Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series.","A hallmark of severe COVID-19 is coagulopathy, with 71.4% of patients who die of COVID-19 meeting ISTH criteria for disseminated intravascular coagulation (DIC) while only 0.6% of patients who survive meet these criteria (1). Additionally, it has become clear that this is not a bleeding diathesis but rather a predominantly pro-thrombotic DIC with high venous thromboembolism rates, elevated D-dimer levels, high fibrinogen levels in concert with low anti-thrombin levels, and pulmonary congestion with microvascular thrombosis and occlusion on pathology in addition to mounting experience with high rates of central line thrombosis and vascular occlusive events (e.g. ischemic limbs, strokes, etc.) observed by those who care for critically ill COVID-19 patients (1-7). There is evidence in both animals and humans that fibrinolytic therapy in Acute Lung Injury and ARDS improves survival, which also points to fibrin deposition in the pulmonary microvasculature as a contributory cause of ARDS and would be expected to be seen in patients with ARDS and concomitant diagnoses of DIC on their laboratory values such as what is observed in more than 70% of those who die of COVID-19 (8-10).","J Thromb Haemost","Wang, Janice","Hajizadeh, Negin","Moore, Ernest E","McIntyre, Robert C","Moore, Peter K","Veress, Livia A","Yaffe, Michael B","Moore, Hunter B","Barrett, Christopher D","32267998"],"abstract":["A hallmark of severe COVID-19 is coagulopathy, with 71.4% of patients who die of COVID-19 meeting ISTH criteria for disseminated intravascular coagulation (DIC) while only 0.6% of patients who survive meet these criteria (1). Additionally, it has become clear that this is not a bleeding diathesis but rather a predominantly pro-thrombotic DIC with high venous thromboembolism rates, elevated D-dimer levels, high fibrinogen levels in concert with low anti-thrombin levels, and pulmonary congestion with microvascular thrombosis and occlusion on pathology in addition to mounting experience with high rates of central line thrombosis and vascular occlusive events (e.g. ischemic limbs, strokes, etc.) observed by those who care for critically ill COVID-19 patients (1-7). There is evidence in both animals and humans that fibrinolytic therapy in Acute Lung Injury and ARDS improves survival, which also points to fibrin deposition in the pulmonary microvasculature as a contributory cause of ARDS and would be expected to be seen in patients with ARDS and concomitant diagnoses of DIC on their laboratory values such as what is observed in more than 70% of those who die of COVID-19 (8-10)."],"journal":"J Thromb Haemost","authors":["Wang, Janice","Hajizadeh, Negin","Moore, Ernest E","McIntyre, Robert C","Moore, Peter K","Veress, Livia A","Yaffe, Michael B","Moore, Hunter B","Barrett, Christopher D"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267998","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jth.14828","keywords":["Acute Respiratory Distress Syndrome (ARDS)","COVID-19","Case Report","Fibrinolysis","Tissue Plasminogen Activator (tPA)"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663609715835273216,"score":207.89778},{"pmid":32203709,"pmcid":"PMC7118607","title":"Treatment for severe acute respiratory distress syndrome from COVID-19.","text":["Treatment for severe acute respiratory distress syndrome from COVID-19.","Lancet Respir Med","Matthay, Michael A","Aldrich, J Matthew","Gotts, Jeffrey E","32203709"],"journal":"Lancet Respir Med","authors":["Matthay, Michael A","Aldrich, J Matthew","Gotts, Jeffrey E"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32203709","week":"202013|Mar 23 - Mar 29","doi":"10.1016/S2213-2600(20)30127-2","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352133643141120,"score":84.93845},{"pmid":32085846,"title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","text":["Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","Lancet Respir Med","Xu, Zhe","Shi, Lei","Wang, Yijin","Zhang, Jiyuan","Huang, Lei","Zhang, Chao","Liu, Shuhong","Zhao, Peng","Liu, Hongxia","Zhu, Li","Tai, Yanhong","Bai, Changqing","Gao, Tingting","Song, Jinwen","Xia, Peng","Dong, Jinghui","Zhao, Jingmin","Wang, Fu-Sheng","32085846"],"journal":"Lancet Respir Med","authors":["Xu, Zhe","Shi, Lei","Wang, Yijin","Zhang, Jiyuan","Huang, Lei","Zhang, Chao","Liu, Shuhong","Zhao, Peng","Liu, Hongxia","Zhu, Li","Tai, Yanhong","Bai, Changqing","Gao, Tingting","Song, Jinwen","Xia, Peng","Dong, Jinghui","Zhao, Jingmin","Wang, Fu-Sheng"],"date":"2020-02-23T11:00:00Z","year":2020,"_id":"32085846","week":"20208|Feb 17 - Feb 23","doi":"10.1016/S2213-2600(20)30076-X","link_erratum_in":"32109426","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663352134543867904,"score":78.39465},{"pmid":32228035,"title":"Covid-19 Does Not Lead to a \"Typical\" Acute Respiratory Distress Syndrome.","text":["Covid-19 Does Not Lead to a \"Typical\" Acute Respiratory Distress Syndrome.","Am J Respir Crit Care Med","Gattinoni, Luciano","Coppola, Silvia","Cressoni, Massimo","Busana, Mattia","Chiumello, Davide","32228035"],"journal":"Am J Respir Crit Care Med","authors":["Gattinoni, Luciano","Coppola, Silvia","Cressoni, Massimo","Busana, Mattia","Chiumello, Davide"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228035","week":"202014|Mar 30 - Apr 05","doi":"10.1164/rccm.202003-0817LE","keywords":["ARDS","COVID-19","Gas exchange","Mechanical Ventilation","Pulmonary circulation"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352135389020160,"score":77.0176},{"pmid":32279018,"title":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports.","text":["Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports.","J Crit Care","Henry, Brandon Michael","Lippi, Giuseppe","32279018"],"journal":"J Crit Care","authors":["Henry, Brandon Michael","Lippi, Giuseppe"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279018","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jcrc.2020.03.011","keywords":["Acute respiratory distress syndrome","COVID-19","Coronavirus","Extracorporeal life support"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663890921987506176,"score":75.0528}]}